MML Investors Services LLC Purchases 946,422 Shares of Kenvue Inc. (NYSE:KVUE)

MML Investors Services LLC boosted its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 528.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,125,552 shares of the company's stock after purchasing an additional 946,422 shares during the period. MML Investors Services LLC owned about 0.06% of Kenvue worth $24,031,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in KVUE. Norges Bank bought a new position in shares of Kenvue in the fourth quarter worth about $521,348,000. Franklin Resources Inc. raised its stake in shares of Kenvue by 61.5% in the fourth quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock worth $912,059,000 after acquiring an additional 16,269,721 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Kenvue by 12.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after acquiring an additional 10,682,003 shares during the last quarter. Boston Partners raised its stake in shares of Kenvue by 36.9% in the fourth quarter. Boston Partners now owns 23,595,963 shares of the company's stock worth $503,145,000 after acquiring an additional 6,366,097 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of Kenvue in the fourth quarter worth about $98,926,000. 97.64% of the stock is owned by institutional investors.

Kenvue Stock Up 1.2 %

Shares of Kenvue stock traded up $0.28 on Friday, hitting $23.03. The company had a trading volume of 22,249,585 shares, compared to its average volume of 17,119,714. The firm has a market capitalization of $44.19 billion, a P/E ratio of 43.45, a P/E/G ratio of 2.62 and a beta of 1.02. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The stock has a 50-day moving average of $23.03 and a 200-day moving average of $22.45.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.56%. The ex-dividend date is Wednesday, May 14th. Kenvue's dividend payout ratio is presently 154.72%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Redburn Atlantic assumed coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target for the company. Canaccord Genuity Group boosted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a report on Wednesday, March 5th. Barclays decreased their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Citigroup boosted their price objective on shares of Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a report on Monday, April 14th. Finally, Evercore ISI assumed coverage on shares of Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 price objective for the company. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $24.42.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.